PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,556,000 | -73.1% | 144,624 | -68.2% | 0.20% | -50.2% |
| Q2 2019 | $5,774,000 | -73.9% | 454,300 | -20.4% | 0.40% | -61.0% |
| Q1 2019 | $22,141,000 | +129.5% | 570,800 | +20.4% | 1.02% | +54.1% |
| Q4 2018 | $9,647,000 | +147.3% | 474,100 | +457.1% | 0.66% | +198.2% |
| Q3 2018 | $3,901,000 | -22.5% | 85,100 | 0.0% | 0.22% | -24.4% |
| Q2 2018 | $5,033,000 | +158.5% | 85,100 | +332.0% | 0.30% | +183.7% |
| Q4 2017 | $1,947,000 | -46.6% | 19,700 | -83.4% | 0.10% | -65.3% |
| Q4 2016 | $3,644,000 | – | 118,700 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |